Skip to content
10-K

Annual Report

VitaNova Life Sciences Corporation VNOV

0001683168-25-005368

← back to feed
Filed
Jul 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 17, 2025 25.01M sh
Shares Diluted FY 2025 · Apr 30, 2025 25.01M sh
Shares Diluted FY 2025 · Apr 30, 2024 10.64M sh
Operating Cash Flow FY 2025 · Apr 30, 2025 $192.77K
Operating Cash Flow FY 2025 · Apr 30, 2024 −$375.88K
Stockholders Equity FY 2025 · Apr 30, 2025 $1.91M
Stockholders Equity FY 2025 · Apr 30, 2024 $1.06M
Stockholders Equity FY 2025 · Apr 30, 2023 −$59.22K
Current Liabilities FY 2025 · Apr 30, 2025 $347.57K
Current Liabilities FY 2025 · Apr 30, 2024 $136.92K
Total Liabilities FY 2025 · Apr 30, 2025 $347.57K
Total Liabilities FY 2025 · Apr 30, 2024 $136.92K
Current Assets FY 2025 · Apr 30, 2025 $2.26M
Current Assets FY 2025 · Apr 30, 2024 $1.19M
Total Assets FY 2025 · Apr 30, 2025 $2.26M
Total Assets FY 2025 · Apr 30, 2024 $1.19M
Eps Diluted FY 2025 · Apr 30, 2025 $0.03
Eps Diluted FY 2025 · Apr 30, 2024 $0.01
Eps Basic FY 2025 · Apr 30, 2025 $0.03
Eps Basic FY 2025 · Apr 30, 2024 $0.01
Sga Expense FY 2025 · Apr 30, 2025 $158.12K
Sga Expense FY 2025 · Apr 30, 2024 $86.75K
Net Income FY 2025 · Apr 30, 2025 $850.75K
Net Income FY 2025 · Apr 30, 2024 $140.87K
Operating Income FY 2025 · Apr 30, 2025 $1.21M
Operating Income FY 2025 · Apr 30, 2024 $205.63K
Gross Profit FY 2025 · Apr 30, 2025 $1.58M
Gross Profit FY 2025 · Apr 30, 2024 $377.71K
Cost Of Revenue FY 2025 · Apr 30, 2025 $1.09M
Cost Of Revenue FY 2025 · Apr 30, 2024 $192.98K
Revenue FY 2025 · Apr 30, 2025 $2.66M
Revenue FY 2025 · Apr 30, 2024 $570.69K